Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$545M |
| 2 |
Danaher
DHR
|
+$429M |
| 3 |
PayPal
PYPL
|
+$426M |
| 4 |
XYZ
Block Inc
XYZ
|
+$397M |
| 5 |
Intuitive Surgical
ISRG
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$724M |
| 2 |
McDonald's
MCD
|
+$704M |
| 3 |
UnitedHealth
UNH
|
+$675M |
| 4 |
JPMorgan Chase
JPM
|
+$570M |
| 5 |
Booking.com
BKNG
|
+$559M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.98% |
| 2 | Healthcare | 17.07% |
| 3 | Consumer Discretionary | 16.52% |
| 4 | Financials | 12.13% |
| 5 | Communication Services | 11.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Mueller Water Products
MWA
$3.95B
| $7.24M | 0.01% |
721,373
+231,223
| +47% | +$2.32M |
|
|
SWAV
452
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $7.11M | 0.01% |
+212,466
| New | +$7.06M |
|
453
AnaptysBio
ANAB
$1.58B
| $7.04M | 0.01% |
96,391
-9
| -0% | -$621 |
|
454
Alcoa
AA
$11.9B
| $7.02M | 0.01% |
249,415
+629
| +0.3% | +$18K |
|
455
Cognex
CGNX
$10.9B
| $6.73M | 0.01% |
+132,366
| New | +$6.34M |
|
|
WCN
456
Waste Connections
WCN
$42.2B
| $6.36M | 0.01% |
71,803
+2,844
| +4% | +$234K |
|
457
Spyre Therapeutics
SYRE
$8.54B
| $6.25M | 0.01% |
31,044
-23,028
| -43% | -$4.8M |
|
458
First Solar
FSLR
$22.7B
| $6.22M | 0.01% |
+117,713
| New | +$5.93M |
|
|
PE
459
DELISTED
PARSLEY ENERGY INC
PE
| $6.16M | 0.01% |
+319,324
| New | +$5.86M |
|
|
RDC
460
DELISTED
Rowan Companies Plc
RDC
| $6.12M | 0.01% |
567,597
-67,720
| -11% | -$789K |
|
461
Hudbay
HBM
$10.1B
| $6.11M | 0.01% |
854,169
-514,026
| -38% | -$3.18M |
|
|
GTLS
462
DELISTED
Chart Industries
GTLS
| $6M | 0.01% |
+66,273
| New | +$5.35M |
|
463
Patterson-UTI
PTEN
$3.98B
| $5.75M | 0.01% |
409,864
-443,152
| -52% | -$5.81M |
|
|
BPL
464
DELISTED
Buckeye Partners, L.P.
BPL
| $5.69M | 0.01% |
+167,245
| New | +$5.41M |
|
465
Norfolk Southern
NSC
$75.4B
| $5.63M | 0.01% |
+30,149
| New | +$5.21M |
|
|
FSTX
466
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $5.55M | 0.01% |
132,320
-22
| -0% | -$927 |
|
|
MMP
467
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $5.23M | 0.01% |
+86,247
| New | +$5.21M |
|
468
Viking Therapeutics
VKTX
$3.7B
| $5.1M | 0.01% |
512,695
-108,094
| -17% | -$905K |
|
|
ICD
469
DELISTED
Independence Contract Drilling, Inc.
ICD
| $4.94M | ﹤0.01% |
89,173
-105
| -0.1% | -$6.81K |
|
470
Halliburton
HAL
$26.9B
| $4.92M | ﹤0.01% |
167,922
-274,551
| -62% | -$8.29M |
|
471
Houlihan Lokey
HLI
$8.77B
| $4.85M | ﹤0.01% |
+105,815
| New | +$4.67M |
|
472
Armstrong World Industries
AWI
$7.38B
| $4.44M | ﹤0.01% |
+55,960
| New | +$3.9M |
|
|
DBVT
473
DBV Technologies
DBVT
$799M
| $4.13M | ﹤0.01% |
53,629
+58
| +0.1% | +$4.41K |
|
|
IMGN
474
DELISTED
Immunogen Inc
IMGN
| $3.99M | ﹤0.01% |
1,471,676
+398,855
| +37% | +$1.73M |
|
475
Amgen
AMGN
$208B
| $3.85M | ﹤0.01% |
+20,286
| New | +$3.87M |
|
Similar funds
Jennison Associates's Q1 2019 Portfolio in Review
As of Q1 2019, Jennison Associates held 723 positions worth $101B, up 13% from $89.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Jennison Associates withdrew a net $3.72B in Q1 2019, closing 96 positions and reducing 294 holdings. Its most notable exit was Booking.com, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Danaher worth $490M.
- Jennison Associates's largest Q1 2019 buy was Danaher: 4,186,042 shares worth $490M.
- Jennison Associates added most to lululemon athletica in Q1 2019, an estimated $545M increase.
- Jennison Associates's biggest Q1 2019 reduction was Goldman Sachs, cutting an estimated $724M.
- Jennison Associates fully exited Booking.com in Q1 2019, selling an estimated $559M.
- Jennison Associates's ten largest holdings make up 31% of its $101B portfolio in Q1 2019.
- Jennison Associates opened 83 new positions and closed 96 in Q1 2019.
- Jennison Associates's portfolio value rose 13% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q1 2019, filed 10 May 2019.